Kevin Freeman-Cook

Kevin is the Vice President of Medicinal and Computational Chemistry, leading the design and synthesis of targeted protein degraders at Plexium.

Kevin joined Plexium in 2022 with extensive pharmaceutical industry experience. Before joining Plexium, Kevin worked for twenty-two years at Pfizer, where he held positions of increasing responsibility, including Research Fellow. Kevin led numerous medicinal chemistry teams and drug discovery programs during this time. Kevin spent ten years in Groton, CT working in the therapeutic areas of allergy and respiratory disease, inflammation, antibacterials, oncology, and diabetes. In 2009, Kevin moved to Pfizer’s La Jolla, CA site, where he focused on medicinal chemistry design in oncology. Over these years, Kevin worked in and led teams that have nominated five compounds for clinical development across multiple therapeutic areas. Dr. Freeman-Cook received his BA in chemistry from Carleton College in 1994 and a Ph.D. in organic chemistry from the University of Colorado Boulder in 1999.